Chronic Pelvic Pain Syndrome
Conditions
Keywords
Pulsed Electromagnetic, Hydrotherapy, Chronic non-bacterial prostatitis, pelvic pain
Brief summary
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research
Detailed description
Chronic pelvic pain syndrome is a multifactorial condition characterized by persistent pelvic pain, functional limitations, and impaired quality of life. Pulsed electromagnetic field therapy (PEMF) and hydrotherapy have been proposed as non-pharmacological interventions to address the underlying mechanisms of chronic pain. PEMF may reduce pain by modulating inflammatory responses, enhancing microcirculation, promoting tissue healing, and influencing neural pain pathways. Hydrotherapy may provide therapeutic benefits through the combined effects of warm water, buoyancy, and hydrostatic pressure, leading to muscle relaxation, reduced pelvic floor tension, improved circulation, and enhanced physical function. Previous clinical investigations have demonstrated favorable effects of both interventions on pain intensity, urinary symptoms, functional status, and quality of life in individuals with chronic pelvic pain conditions. Therefore, the combination of PEMF and hydrotherapy may offer a comprehensive therapeutic approach for managing chronic pelvic pain syndrome and improving patient outcomes
Interventions
Participants allocated to the experimental group will receive pulsed electromagnetic field therapy using a low-frequency PEMF device applied over the suprapubic and perineal regions. Participants will be positioned comfortably in a supine lying position during treatment. The electromagnetic field will be delivered at therapeutic frequencies and intensities according to the manufacturer's recommendations for pain management and soft tissue healing. Each treatment session will last approximately 20-30 minutes, administered three sessions per week for 12 weeks.
DEVICEhydrotherapy
Participants allocated to the hydrotherapy group will undergo a supervised aquatic exercise program conducted in a therapeutic pool with warm water maintained at 32-34°C. Each session will last approximately 45-60 minutes, three times per week for 12 weeks. The intervention will include gentle warm-up exercises, pelvic mobility exercises, stretching, relaxation techniques, and low-to-moderate intensity aerobic and strengthening activities performed in water.
OTHERtraditional physical therapy program
The intervention will be administered by a licensed physiotherapist and will consist of pelvic floor muscle awareness training, relaxation exercises, diaphragmatic breathing, stretching exercises, and controlled pelvic floor muscle contractions. Treatment sessions will be conducted three times per week for 12 weeks, with each session lasting approximately 30-45 minutes. Participants will also be instructed to perform a structured home exercise program on non-treatment days
Sponsors
Horus University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
computer based and using sealed envelopes
Intervention model description
comparing the effect of pulsed electromagnetic therapy versus hydrotherapy when added with traditional treatment in cases of chronic pelvic pain syndrome
Eligibility
Sex/Gender
MALE
Age
42 Years to 52 Years
Healthy volunteers
Yes
Inclusion criteria
* male patients aged 42 - 50 years * chronic non bacterial prostatitis * Diagnosis of Chronic Non-Bacterial Prostatitis/Chronic Pelvic Pain Syndrome (NIH Category III) confirmed by a urologist. * Presence of pelvic, perineal, suprapubic, testicular, penile, or ejaculatory pain for at least 3 months within the previous 6 months. * Stable medical treatment for at least 4 weeks before enrollment, if receiving medications. * Ability to understand study procedures and provide written informed consent. Willingness to refrain from initiating new treatments for prostatitis during the study period.
Exclusion criteria
* Diagnosis of acute bacterial prostatitis * History of prostate cancer, bladder cancer, or other pelvic malignancy * Previous prostate surgery within the last 12 months * Contraindications to hydrotherapy, including: Open wounds, Active skin infections, Uncontrolled epilepsy, Severe cardiac insufficiency
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| chronic pelvic pain | 12 weeks | will be measured by visual analogue scale interpreting pain intensity with minimum score = 0 and maximum score = 10, and lower scores means a better improvement |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| participants quality of life | 12 weeks | International consultation on incontinence questionnaire short-form is scored from 0 to 21 points with the lower scores means a better improvement |
Countries
Jordan
Outcome results
None listed